Integra LifeSciences Holdings Corporation
IART
$22.24
-$1.71-7.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.01% | -154.86% | -396.41% | -113.54% | -62.54% |
| Total Depreciation and Amortization | 44.23% | -28.79% | 42.34% | -1.85% | 5.05% |
| Total Amortization of Deferred Charges | -2.30% | -5.79% | 2.53% | -26.03% | -15.85% |
| Total Other Non-Cash Items | 22.20% | -28.52% | -4.51% | -9.43% | 60.35% |
| Change in Net Operating Assets | -218.77% | 109.96% | 106.26% | 45.20% | -1.59% |
| Cash from Operations | -13.63% | -16.01% | 42.87% | -39.76% | -31.15% |
| Capital Expenditure | -20.64% | -126.69% | -91.07% | -12.85% | -69.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 164.75% | 257.74% | -- | -- | -- |
| Cash from Investing | 92.58% | -35.07% | -1,972.28% | -293.79% | -4.39% |
| Total Debt Issued | 94.51% | -83.45% | 1,076.00% | 3,532.35% | 180.00% |
| Total Debt Repaid | -61.71% | 26.86% | -442.18% | -21.77% | 77.09% |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | 175.06% | -94.19% |
| Repurchase of Common Stock | -730.25% | 99.86% | -48,054.81% | 97.99% | -15.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -3.77% | 59.90% | -776.72% | 320.48% | 92.95% |
| Foreign Exchange rate Adjustments | -201.04% | 258.95% | -428.17% | -629.67% | -32.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,069.21% | 99.78% | -20,739.45% | 311.33% | 104.83% |
